Product Information

TOBRAMYCIN 300 MG/5 ML AMPULE is a generic product labeled by Ritedose Pharmaceuticals, LLC, priced at $1.0392 per ML under NDC 76204002956. Its NADAC has been published 41 times since Feb 11, 2026.

FDA first approved this application on May 28, 2014. Its Orange Book therapeutic-equivalence code is AN.

TOBRAMYCIN 300 MG/5 ML AMPULE

Tobramycin
$1.0392per ML

Strength

300 mg/5mL

NDC

76204002956

Classification

Generic

Dosage Form

SOLUTION

Route

RESPIRATORY (INHALATION)

Effective Date

11/18/2026

Active Ingredients

TOBRAMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA201422

FDA Approved

5/28/2014

TE Code

AN

On Market Since

3/25/2025

Pharmacological Classes

Price Statistics

The NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has been published 41 times since Feb 11, 2026, and over the history we have for it it has declined 10.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0392 per ML
All-time high$1.1631 (Feb 11, 2026)
All-time low$1.0392 (Nov 18, 2026)
52-week high$1.1631
52-week low$1.0392
Median price$1.0840
Average price$1.0824
Largest weekly change-4.9% (Feb 18, 2026)
Weeks tracked41
Tracking sinceFeb 11, 2026

Price History

1W

-1.5%

1M

-4.1%

3M

-4.2%

6M

-4.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-10.6%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOBRAMYCIN 300 MG/5 ML AMPULE?

The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 300 MG/5 ML AMPULE, manufactured by Ritedose Pharmaceuticals, LLC, is $1.0392 per ML (NDC 76204002956), effective Nov 18, 2026.

How has the price of TOBRAMYCIN 300 MG/5 ML AMPULE changed over time?

Over the history we have for it, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has declined 10.6%. It has been tracked across 41 weekly CMS publications since Feb 11, 2026.

What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 300 MG/5 ML AMPULE?

Since Feb 11, 2026, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has ranged from a low of $1.0392 (Nov 18, 2026) to a high of $1.1631 (Feb 11, 2026), with a median of $1.0840 per ML.

Are there cheaper alternatives to TOBRAMYCIN 300 MG/5 ML AMPULE?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN 300 MG/5 ML AMPULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TOBRAMYCIN 300 MG/5 ML AMPULE?

TOBRAMYCIN 300 MG/5 ML AMPULE (NDC 76204002956) is labeled by Ritedose Pharmaceuticals, LLC, and CMS classifies it as a generic product.